In last trading session, Telomir Pharmaceuticals Inc (NASDAQ:TELO) saw 0.31 million shares changing hands with its beta currently measuring -1.99. Company’s recent per share price level of $4.58 trading at -$0.45 or -8.95% at ring of the bell on the day assigns it a market valuation of $136.31M. That closing price of TELO’s stock is at a discount of -105.02% from its 52-week high price of $9.39 and is indicating a premium of 32.1% from its 52-week low price of $3.11. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.17 million shares which gives us an average trading volume of 162.98K if we extend that period to 3-months.
Telomir Pharmaceuticals Inc (NASDAQ:TELO) trade information
Upright in the red during last session for losing -8.95%, in the last five days TELO remained trading in the green while hitting it’s week-highest on Thursday, 03/13/25 when the stock touched $4.58 price level, adding 15.19% to its value on the day. Telomir Pharmaceuticals Inc’s shares saw a change of 11.17% in year-to-date performance and have moved 5.29% in past 5-day. Telomir Pharmaceuticals Inc (NASDAQ:TELO) showed a performance of 7.76% in past 30-days. Number of shares sold short was 1.87 million shares which calculate 14.69 days to cover the short interests.
Telomir Pharmaceuticals Inc (NASDAQ:TELO)’s Major holders
Insiders are in possession of 34.17% of company’s total shares while institution are holding 12.06 percent of that, with stock having share float percentage of 18.32%. Investors also watch the number of corporate investors in a company very closely, which is 12.06% institutions for Telomir Pharmaceuticals Inc that are currently holding shares of the company.
On the other hand, Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 833.23 shares of worth $3.82 million or 2.80% of the total outstanding shares. The later fund manager was in possession of 410.76 shares on Dec 31, 2024 , making its stake of worth around $1.88 million in the company or a holder of 1.38% of company’s stock.
